Ignite Creation Date:
2025-12-24 @ 9:08 PM
Ignite Modification Date:
2026-01-22 @ 7:50 AM
Study NCT ID:
NCT06524804
Status:
TERMINATED
Last Update Posted:
2024-12-18
First Post:
2024-07-24
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase Ib/II Study of BY101298 , an Oral DNA-PK Inhibitor, Combined with Radiotherapy in Patients with Malignant Solid Tumors
Sponsor:
Chengdu Baiyu Pharmaceutical Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-05-15
Start Date Type:
ACTUAL
Primary Completion Date:
2024-10-18
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-10-18
Completion Date Type:
ACTUAL
First Submit Date:
2024-07-24
First Submit QC Date:
None
Study First Post Date:
2024-07-29
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-12-16
Last Update Post Date:
2024-12-18
Last Update Post Date Type:
ACTUAL